Keyphrases
Organoid Models
53%
Organoids
53%
Tumor
46%
Rhabdomyosarcoma
46%
Transcription Factor
36%
Drug Sensitivity
34%
Interleukin-22 (IL-22)
30%
Human Intestinal Organoids
30%
Paneth Cells
30%
Cell Formation
30%
Immune Suppression
30%
Enteroendocrine
30%
Repressor
30%
Patient Outcomes
30%
Enteroendocrine Cells
30%
Immune Cells
30%
CRISPR Interference (CRISPRi)
30%
Cell State
30%
Single-cell Transcriptomics
30%
Hepatoblastoma
30%
Human Fetal Brain
30%
Tumor Organoids
24%
Stem Cells
19%
Patient-derived Organoids
18%
Wnt Signaling
18%
Multidimensional Profiling
15%
Mesenchymal Tumor
15%
Cell Differentiation
15%
Central Nervous System
15%
Sensitivity Profile
15%
Differentiation State
13%
Fetal-like
12%
Cas9 Protein
11%
Cellular Differentiation
8%
Myogenic Differentiation
8%
Pediatric Rhabdomyosarcoma
8%
Clinical High Risk
8%
Mesenchymal Origin
8%
Hormone-producing Cells
7%
Knockout Screen
7%
CRISPR Knockout
7%
Gastrointestinal Motility
7%
Gastrointestinal Secretion
7%
Epithelium
7%
Syngeneic
7%
Stomach
7%
Brain Cancer
7%
Enterochromaffin Cells
7%
Progenitor Expansion
7%
Human Small Intestine
7%
Medicine and Dentistry
Organoid
100%
Rhabdomyosarcoma
46%
Neoplasm
40%
Transcriptomics
36%
Drug Sensitivity
32%
Hepatoblastoma
30%
Immunocompetent Cell
30%
Immunosuppressive Treatment
30%
Clustered Regularly Interspaced Short Palindromic Repeat
23%
Transcription Factors
20%
Tumor
19%
Paneth Cell
15%
Interleukin 22
15%
Enteroendocrine Cell
15%
Repressor Gene
15%
Cell Differentiation
15%
Stem Cell
12%
Central Nervous System
12%
Pediatrics
11%
Targeted Therapy
10%
Cas9
8%
Small Intestine
7%
Polypeptide Antibiotic Agent
6%
Brain Development
6%
Extracellular Matrix
6%
In Vitro
6%
Pluripotent Stem Cell
6%
Somatics
6%
Brain Cancer
6%
Epithelioma
5%
High Throughput Screening
5%
RNA Sequencing
5%
Liver Cancer
5%
Histone Deacetylase Inhibitor
5%
Xenobiotic Metabolism
5%
Regulon
5%
Bile Acid Metabolism
5%
Drug Analysis
5%
Lipid Metabolism
5%
Liver Function
5%
Lymphoid Enhancer Factor 1
5%
